This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
ThermoGenesis Holdings Gestione
Gestione criteri di controllo 3/4
We currently do not have sufficient information about the CEO.
Informazioni chiave
Chris Xu
Amministratore delegato
US$699.0k
Compenso totale
| Percentuale dello stipendio del CEO | 74.2% |
| Mandato del CEO | 6.9yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 6.6yrs |
| Durata media del Consiglio di amministrazione | 6.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$699k | US$519k | -US$11m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$11m |
| Dec 31 2021 | US$748k | US$500k | -US$11m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$2m | US$505k | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$12m |
| Dec 31 2019 | US$472k | US$472k | -US$9m |
| Sep 30 2019 | n/a | n/a | -US$13m |
| Jun 30 2019 | n/a | n/a | -US$13m |
| Mar 31 2019 | n/a | n/a | -US$39m |
| Dec 31 2018 | US$653k | US$460k | -US$40m |
| Sep 30 2018 | n/a | n/a | -US$32m |
| Jun 30 2018 | n/a | n/a | -US$32m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | US$1m | US$216k | -US$6m |
Compensazione vs Mercato: Chris's total compensation ($USD699.00K) is above average for companies of similar size in the German market ($USD417.54K).
Compensazione vs guadagni: Chris's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Chris Xu (52 yo)
6.9yrs
Mandato
US$699,000
Compensazione
Dr. Xiaochun Xu, also known as Chris, M.B.A. Ph D., is the Founder, Chairman and Chief Executive Officer of Boyalife Group since July 2009.He serves as an Advisor at WI Harper Group. Dr. Xu has been the C...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.9yrs | US$699.00k | Nessun dato | |
| CFO & Corporate Secretary | 6.6yrs | US$325.00k | 0.00064% $ 21.6 | |
| COO & Director | 5.8yrs | US$554.00k | 0% $ 0 |
6.6yrs
Durata media
52yo
Età media
Gestione esperta: THRP's management team is seasoned and experienced (6.6 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman of the Board & CEO | 7.6yrs | US$699.00k | Nessun dato | |
| COO & Director | 1.8yrs | US$554.00k | 0% $ 0 | |
| Independent Director | 6.7yrs | US$54.50k | 0% $ 0 | |
| Member of Clinical & Scientific Advisory Board | 9.4yrs | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | 7.6yrs | Nessun dato | Nessun dato | |
| Independent Director | less than a year | US$99.00k | Nessun dato | |
| Independent Director | 6.8yrs | US$56.00k | 0% $ 0 | |
| Independent Director | less than a year | Nessun dato | Nessun dato |
6.7yrs
Durata media
57yo
Età media
Consiglio di amministrazione esperto: THRP's board of directors are considered experienced (6.7 years average tenure).